About Us
Company Profile
Corporate Culture
Development
Organizational
Responsibility
Partners
Business Scope
CRO Services
Transformation Of Hospital Preparations
Registration Affairs
Medical Services
Cultivation Of Major TCM Varieties
SMO Service
Therapeutic Area
Breathe
Gynecology And Reproductive Medicine
Pediatrics
Tumor
Orthopedics
Cardiovascular And Cerebrovascular
Digestion
Endocrinology And Metabolism
Dermatology
Proctology
Urology
Neurological And Psychiatric Disorders
Qualification And Honor
Qualification And Honor
News
Company News
Industry News
Contact Us
EN
中文 EN
Company News
Industry News
Home - News and Information
Company News
Evidence-Based Empowerment | Lead Site Initiation Meeting for the Bailing Tablets Clinical Trial in the Treatment of Vitiligo Successfully Held
On August 3, the lead site initiation meeting for the clinical trial on the efficacy and safety of Bailing Tablets in the treatment of non-segmental slowly progressive vitiligo was successfully held in the academic hall on the first floor of the Department of Dermatology at the First Affiliated Hospital of Air Force Medical University.
2026-08-03
Insight into Hong Kong & Macao, Building Bridges for Global Expansion" — Evidence-Based Research on the Hong Kong and Macao Registration Pathways for Pharmaceutical Enterprises in the Greater Bay Area
In-Depth Analysis of Compliance Pathways for Greater Bay Area TCM Enterprises "Going Global": A Comprehensive Guide to Hong Kong's HKC Tiered Review Policy, Macao's Fast-Track "Non-Drug" Filing, and Greater Bay Area Two-Way Simplified Registration, with Real-World Case Studies and Key Pitfalls to Avoid
2026-07-25
Good News | Guangzhou EBM Elected as Council Member Unit of the Second Council of the Evidence-Based Medicine Branch, China Ethnic Medicine Association
From June 26 to 29, 2026, the 2026 Annual Academic Conference of the Evidence-Based Medicine Branch of the China Ethnic Medicine Association was grandly held in Hohhot, Inner Mongolia Autonomous Region.
2026-06-30
When a Millennium-Old Classic Formula Meets the "Research-Oriented Pharmacy" – Xiao Chai Hu Granules Real-World Study Project Launched at Beijing Tongrentang Foshan Chain
On the afternoon of June 24, the "Guanghua Xiao Chai Hu Granules – Beijing Tongrentang Foshan Chain Research-Oriented Pharmacy Real-World Study Project" deployment meeting was held at the headquarters of Beijing Tongrentang Foshan Chain Pharmacy. This marks another significant deployment of the project in Guangdong following its launch in Guangzhou, signaling that the nation's first OTC drug research-oriented pharmacy project has officially entered the Foshan market.
2026-06-24
From Evidence to Intelligent Evidence: Salon on AI New Paradigm for TCM Enterprises Concludes Successfully
On May 28, Guangzhou Evidence-Based Medicine Technology Co., Ltd. (hereinafter referred to as "Guangzhou EBM"), together with the Greater Bay Area Chapter of the CEIBS Healthcare Industry Association, visited the Alibaba Center in Guangzhou to co-host the "In-Depth Closed-Door Meeting on AI Transformation Implementation for Pharmaceutical Enterprises" in partnership with DingTalk Wukong and Maolu Academy. The event was designed to help healthcare companies break through barriers in compliance, data management, and cross-functional collaboration, enabling a systematic leap from individual productivity enhancement to organizational evolution.
2026-05-28
Embracing the AI Era, Empowering Organizational Evolution – Guangzhou EBM Management Team Attends AI Hands-On Training at Alibaba Center Guangzhou
Embracing the AI Era, Empowering Organizational Evolution – Guangzhou EBM Management Team Attends AI Hands-On Training at Alibaba Center Guangzhou
2026-05-18
2026-09-11
Guangzhou EBM Deputy GM Zhuo Jingxian Appointed to Two Committees of Guangdong Biomedical Innovation Technology Association
Guangzhou EBM Deputy GM Zhuo Jingxian was appointed Vice Chair of the TCM Research Committee and a member of the New Drug R&D and Clinical Committee of the Guangdong Biomedical Innovation Technology Association.
2026-09-11
From Pilot to Paradigm: Guangzhou EBM Drives "Research-Oriented Pharmacy RWS" into a New Stage of Quality Improvement and Expansion
The Xiaochaihu Granules research-oriented pharmacy RWS project has moved from pilot to expansion. Guangzhou EBM, as the core partner, built a GCP-like quality management system. As of August 31, 201 enrolled cases were completed, with plans to expand to 40 stores in 6 provinces by December.
2026-09-05
Exhibition Review | Guangzhou EBM Showcases Full-Chain TCM R&D Solutions at CMC Expo
From September 4 to 5, 2026, Guangzhou EBM showcased its full-chain TCM R&D solutions at the 8th CMC Expo in Suzhou, presenting six core services including CRO, formulation transformation, and major TCM product cultivation.
2026-09-05
2026 Academic Annual Meeting of TCM Clinical Evaluation Committee Held, Research-Oriented Pharmacy Practice Draws Attention
On September 5, 2026, the 2026 Academic Annual Meeting of the TCM Clinical Evaluation Professional Committee was held at the Shandong Mansion, where experts discussed frontier topics in new TCM drug R&D. Vice President Zhang Junhua of Tianjin University of Traditional Chinese Medicine highlighted the research-oriented pharmacy project. Guangzhou EBM is responsible for protocol design, ethical review, and DCT system deployment, exploring a new path for decentralized TCM clinical evaluation.
2026-09-04
Congratulations! Guangzhou Evidence-Based Medicine GM Zhou Jie Appointed Vice Chair of Guangdong TCM Association Committee
The general election meeting of the Special Committee for Human Use Experience and Medical Institution Preparation Transformation of Guangdong Chinese Medicine Association was held at the First Affiliated Hospital of Guangzhou University of Chinese Medicine. Qiu Zhenwen was re-elected as the chairperson. Zhou Jie, General Manager of Guangzhou Evidence-based Medicine, was appointed Vice Chairperson of the 2nd Special Committee, and Wu Yanmei, Deputy General Manager, was appointed Secretary of the Special Committee.
2026-08-26
Macao Pharmaceutical Administration Bureau Delegation Visits Guangdong Biomedical Innovation Technology Association
On August 26, 2026, a delegation led by Cai Bingxiang, Director of the Macao Pharmaceutical Administration Bureau, visited the Guangdong Biomedical Innovation Technology Association. Both sides discussed innovative drugs, TCM, and cell and gene therapy, reaching four cooperation consensuses on policy promotion, clinical trials, talent exchange, and a regular liaison mechanism.
1
2
3
Online Message

With a professional and efficient service system and a comprehensive operational network, Guangzhou Evidence Based Medicine is committed to providing tailored one-stop traditional Chinese medicine research and development full industry chain service solutions for every customer, promoting traditional Chinese medicine to the world and safeguarding the health of more people.

The business area you want to consult